GABA(A) receptors: Diversity and its implications for CNS disease

Neuroscientist

Volumn 5, Issue 6, 1999, Pages 351-361

  Tallman, John F ^a,b   Cassella, James V ^a   White, Geoff ^a   Gallager, Dorothy W ^a  

^a NEUROGEN CORPORATION   (United States)

^b NONE   (United States)

Author keywords

Anxiolytics; Benzodiazepine receptor; Hypnotics; Ligand gated channel; Aminobutyric acid (GABA)

Indexed keywords

2 PHENYL 5H PYRAZOLO[4,3 C]QUINOLIN 3 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; 5 ISOPROPOXY 4 METHYL BETA CARBOLINE 3 CARBOXYLIC ACID ETHYL ESTER; ALPRAZOLAM; BRETAZENIL; DIAZEPAM; FLUMAZENIL; LORAZEPAM; RECEPTOR SUBUNIT; TEMAZEPAM; ZOLPIDEM;

AMNESIA; CENTRAL NERVOUS SYSTEM DISEASE; DRUG EFFECT; DRUG RECEPTOR BINDING; HYPNOSIS; KNOCKOUT GENE; NEUROTRANSMISSION; NONHUMAN; PROTEIN CONFORMATION; RECEPTOR AFFINITY; RECEPTOR DENSITY; REVIEW; SEDATION;

EID: 0032701285     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385849900500610     Document Type: Review

References (49)

1. Paul S. GABA and glycine. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press; 1995. p. 87-94.
2. Sieghart W. Structure and pharmacology of γ-aminobutyric acid A receptor subtypes. Pharmacol Rev 1995;47:181-234.
3. Kaupmann K, Huggel K, Heid J, Flor PJ, Bischoff S, Mickel SJ, et al. Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. Nature 1997;386:239-46.
4. Wess J. G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J 1997;11:346-54.
5. Tallman JF, Paul SM, Skolnick P, Gallager DW. Receptors for the age of anxiety: pharmacology of the benzodiazepines. Science 1980;207:274-81.
6. A receptors. FASEB J 1990;4:146-980.
7. Tallman JF, Gallager DW. The GABA-ergic system: a locus of benzodiazepine action. Annu Rev Neurosci 1985;8:21-44.
8. Schofield PR, Darlison MG, Fujita N, Burt DR, Stephenson FA, Rodriguez H, et al. Sequence and functional expression of the GABA A receptor shows a ligand-gated receptor superfamily. Nature 1987;328:221-7.
9. A receptors depend upon subunit composition. Neuron 1990;4:919-28.
10. Galzi JL, Changeux JP. Neurotransmitter-gated ion channels as unconventional allosteric proteins. Curr Opin Struct Biol 1994;4: 554-65.
11. Galzi JL, DeVillars-Thiery A, Hussy N, Bertrand S, Changeux JP, Bertrand D. Mutations in the channel domain of a neuronal nicotinic receptor convert ion selectivity from cationic to anionic. Nature 1992;359:500-4.
12. A receptor determined by electron microscopic image analysis. J Neurochem 1994;62:815-8.
13. A receptors expressed in SF9 cells. Receptors Channels 1998;6:1-18.
14. A receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 1998;50:291-313.
15. A receptor subunit for benzodiazepine pharmacology. Nature 1989;338:582-4.
16. A receptors. Trends Pharmacol Sci 1997;18:425-9.
17. A receptor complex characteristics in a baculovirus expression system. Recept Channels 1996;4:179-95.
18. Tallman JF, Thomas JW, Gallager DW. GABAergic modulation of benzodiazepine binding site sensitivity. Nature 1978;274:383-5.
19. Monod J, Changeux JP, Wyman J. On the nature of allosteric transitions: a plausible model. J Mol Biol 1965;12:88-118.
20. Changeux JP, Edelstein SJ. Allosteric receptors after 30 years. Neuron 1998;21:959-80.
21. A receptor isoform. Genomics 1994;23:528-33.
22. A receptor gene clusters are derived from an ancestral cluster. Genomics 1995;26:580-6.
23. A receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol 1995;359:154-94.
24. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 1992;12: 1040-63.
25. A receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum. J Neurosci 1992;12:1063-76.
26. Klepner CA, Lippa AS, Benson DI, Sano MC, Beer B. Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors. Pharmacol Biochem Behav 1979;11:457-62.
27. A-benzodiazepine receptors produced in transfected cells. Science 1989;245: 1389-92.
28. A receptor selective for a behavioural alcohol antagonist. Nature 1990;346:648-51.
29. A receptors. Mol Pharmacol 1994;45:810-4.
30. A receptor subunit. Nature 1997;385:820-3.
31. Saxena NC, Macdonald RL. Properties of putative cerebellar GABAA receptor isoforms. Mol Pharmacol 1996;49:567-79.
32. A receptors depend upon subunit composition. Neuron 1990;4:919-28.
33. Perkins KL, Wong RK. The depolarizing GABA response. Can J Physiol Pharmacol 1997;75:516-9.
34. A receptors underlying inhibitory synaptic currents in neocortical pyramidal neurons. J Neurosci 1997;17:7220-7.
35. Magenis RE. Chromosomes and their disorders. In: Bennet JC, Plum F., editors. Cecil's textbook of medicine. Philadelphia: WB Saunders; 1996. p. 150-7.
36. Culiat CT, Stubbs L, Woychik J, Russell L, Johnson D, Rinchik E. Deficiency of the β 3 subunit of the type A GABA receptor causes cleft palate in mice. Nat Genet 1995;11:344-6.
37. A receptor β3 subunit have epilepsy, cleft palate and hypersensitive behavior. Proc Nat Acad Sci U S A 1997;94:4143-8.
38. A-receptor assembly in vivo: lessons from subunit mutant mice. Life Sci 1998;62:1611-5.
39. A receptor subtypes: mice with point mutated diazepam-insensitive GABAa α1 receptors. Soc Neurosci Abstr 1998;24: 1990.
40. Taylor JL, Tinklenberg JR. Cognitive impairment and benzodiazepines. In: Meltzer H, editor. Psychopharmacology: the third generation of progress. New York: Raven Press; 1987. p. 1449-53.
41. Venault P, Chapouthier G, de Carvalho LP, Simiand J, Morre M, Dodd RH, et al. Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks. Nature 1986;321:864-6.
42. Duka T, Stephens D, Dorow R. Cognitive enhancing properties of antagonist β-carbolines: new insights into clinical research on the treatment of dementia. In: Maurer K, Riederer P, Beckman H, editors. Alzheimer's disease: epidemiology, neuropathology, neurochemistry, and clinics. New York: Springer-Verlag; 1990. p. 555-64.
43. Piei L, Hunkeler W, Jauch R, Martin J, Bonetti E. Ro 16-6028. Drugs of the Future 1988;13:730-5.
44. Gallager DW, Lakoski JM, Gonsalves SF, Rauch SL. Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity. Nature 1984;308:74-7.
45. Primus RJ, Yu J, Xu J, Hartnett C, Meyyappan M, Kostas C, et al. Allosteric uncoupling after chronic benzodiazepine exposure of recombinant GABAA receptors exppressed in Sf9 cells: efficacy and subtype selectivity. J Pharmacol Exp Ther 1996;276: 882-90.
46. A receptors by chronic treatment with GABAa and benzodiazepine agonists. J Pharmacol Exp Ther 1995;274: 1484-92.
47. Weerts EM, Ator N, Grech DM, Griffiths RR. Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. J Pharmacol Exp Ther 1998;285:41-53.
48. Hernandez TD, Heninger C, Wilson MA, Gallager DW. Relationship of agonist efficacy to changes in GABA sensitivity and anticonvulsant tolerance following chronic benzodiazepine ligand exposure. Eur J Pharmacol 1989;170:145-55.
49. Goldstein SAN, Colatsky TJ. Ion channels: too complex for rational drug design. Neuron 1996;16:913-9.